GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $66.9 million in its third quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.27.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.22 per share.
The biopharmaceutical company posted revenue of $4.3 million in the period.
Theravance Bio shares have decreased 12 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $28.19, an increase of 9 percent in the last 12 months.